Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 154 No. 12 (2024)

Economic evaluation in the treatment of unruptured intracranial aneurysms in the Swiss healthcare system: a retrospective cost evaluation

DOI
https://doi.org/10.57187/s.3727
Cite this as:
Swiss Med Wkly. 2024;154:3727
Published
10.12.2024

Summary

The choice of modality of treatment for unruptured intracranial aneurysms is based on various clinical aspects and the patient’s preference. Financial considerations should not be among these. To evaluate any financial variations between endovascular and microsurgical treatment of unruptured intracranial aneurysms in the Swiss healthcare system, we retrospectively reviewed 100 consecutive aneurysm cases treated as inpatients in our institution.

Case-based financial data were collected (revenues, costs, net earnings) and compared between the treatments.

Among 100 consecutive aneurysm cases treated at our institution (2021–2023), 58 were unruptured intracranial aneurysm. Treatment was endovascular in 33, microsurgery in 23 and conservative/antibiotic in 2 cases. Length of stay (but not duration in the intensive care unit) was longer after microsurgical treatment. Total median revenues (public insurance, private insurance, material reimbursement) were Swiss Francs (CHF) 30,012.25 with a maximum of CHF 125,337.20 and a minimum of CHF 9543.25. No marked difference was found between the treatment groups (endovascular and microsurgery). Despite the fact that median net earnings per patient were positive (CHF 3655.03), more than one third of all cases led to a net loss for the hospital with a tendency for more stable net earnings in microsurgery cases. The only factor associated with a higher risk of net loss per case was higher implant costs in endovascular cases.

Reimbursement within the Swiss healthcare system does not promote financial bias for decision-making in treatment modality for unruptured intracranial aneurysm. The fact that one third of all cases does not result in positive net earnings (even in the highly paid unruptured intracranial aneurysm sector), although overall net earnings were positive, should be monitored – especially in times of rising costs.

References

  1. Figueroa-Sanchez JA, Ferrigno AS, Hinojosa-González DE, Salgado-Garza G, Martinez HR, Caro-Osorio E, et al. Cost analysis of materials used in the endovascular treatment of unruptured intracranial aneurysms in Mexico. Interv Neuroradiol. 2020 Aug;26(4):476–82. doi: https://doi.org/10.1177/1591019920920954 DOI: https://doi.org/10.1177/1591019920920954
  2. Maud A, Lakshminarayan K, Suri MF, Vazquez G, Lanzino G, Qureshi AI. Cost-effectiveness analysis of endovascular versus neurosurgical treatment for ruptured intracranial aneurysms in the United States. J Neurosurg. 2009 May;110(5):880–6. doi: https://doi.org/10.3171/2008.8.JNS0858 DOI: https://doi.org/10.3171/2008.8.JNS0858
  3. Takao H, Nojo T, Ohtomo K. Cost-effectiveness of treatment of unruptured intracranial aneurysms in patients with a history of subarachnoid hemorrhage. Acad Radiol. 2008 Sep;15(9):1126–32. doi: https://doi.org/10.1016/j.acra.2008.02.017 DOI: https://doi.org/10.1016/j.acra.2008.02.017
  4. Brinjikji W, Kallmes DF, Lanzino G, Cloft HJ. Hospitalization costs for endovascular and surgical treatment of unruptured cerebral aneurysms in the United States are substantially higher than medicare payments. AJNR Am J Neuroradiol. 2012 Jan;33(1):49–51. doi: https://doi.org/10.3174/ajnr.A2739 DOI: https://doi.org/10.3174/ajnr.A2739
  5. Ballas D, Dorling D, Hennig B. The Human Atlas of Europe. Bristol: Policy Press; 2017. p. 79. DOI: https://doi.org/10.56687/9781447332909
  6. Stats OE. Health Care Resources: Physician Density 2013. OECD Stats; 2015.
  7. Bjoernberg A, Phang AY. Euro Health Consumer Index 2018. 2019 Feb. Available from: https://healthpowerhouse.com/media/EHCI-2018/EHCI-2018-report.pdf
  8. Reis Miranda D, Moreno R, Iapichino G. Nine equivalents of nursing manpower use score (NEMS). Intensive Care Med. 1997 Jul;23(7):760–5. doi: https://doi.org/10.1007/s001340050406 DOI: https://doi.org/10.1007/s001340050406
  9. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993 Dec;270(24):2957–63. doi: https://doi.org/10.1001/jama.1993.03510240069035 DOI: https://doi.org/10.1001/jama.270.24.2957
  10. Hoh BL, Chi YY, Dermott MA, Lipori PJ, Lewis SB. The effect of coiling versus clipping of ruptured and unruptured cerebral aneurysms on length of stay, hospital cost, hospital reimbursement, and surgeon reimbursement at the university of Florida. Neurosurgery. 2009 Apr;64(4):614–9. doi: https://doi.org/10.1227/01.NEU.0000340784.75352.A4 DOI: https://doi.org/10.1227/01.NEU.0000340784.75352.A4
  11. Drazin D, Dalfino JC, Donovan M, Friedlich D, Feustel PJ, Popp AJ, et al. Surgonomics of unruptured intracranial aneurysms. J Neurointerv Surg. 2010 Jun;2(2):168–70. doi: https://doi.org/10.1136/jnis.2009.001065 DOI: https://doi.org/10.1136/jnis.2009.001065
  12. Lan M, Liles C, Patel PD, Gannon SR, Chitale RV. Impact of insurance type on national variation in cost of endovascular treatment for unruptured cerebral aneurysms. J Neurointerv Surg. 2021 Jul;13(7):661–8. doi: https://doi.org/10.1136/neurintsurg-2020-016676 DOI: https://doi.org/10.1136/neurintsurg-2020-016676
  13. Wang C, Hui FK, Spiotta AM, Rasmussen PA. The cost of coils implanted in aneurysms: 2 years of clinical data. J Neurointerv Surg. 2014 Jan;6(1):72–5. doi: https://doi.org/10.1136/neurintsurg-2012-010600 DOI: https://doi.org/10.1136/neurintsurg-2012-010600
  14. Duangthongphon P, Kitkhuandee A, Munkong W, Limwattananon P, Waleekhachonloet O, Rattanachotphanit T, et al. Cost-effectiveness analysis of endovascular coiling and neurosurgical clipping for aneurysmal subarachnoid hemorrhage in Thailand. J Neurointerv Surg. 2022 Sep;14(9):942–7. doi: https://doi.org/10.1136/neurintsurg-2021-017970 DOI: https://doi.org/10.1136/neurintsurg-2021-017970

Most read articles by the same author(s)